Press Releases

HeartCare study tests genetic risk of cardiovascular diseaseFeb 19, 2020
Researchers are working with Baylor cardiologists to determine patients’ genetic risk factors for cardiovascular disease
Evenings with Genetics spotlights Turner SyndromeFeb 5, 2020
On Tuesday, Feb. 11, Evenings with Genetics will discuss the genetics and state-of-the art heart care for children with Turner Syndrome.
Cardiovascular disease risk factor targeted for new treatmentFeb 5, 2020
Baylor College of Medicine researchers are beginning trials to test two new drugs that directly target Lp(a) levels.
Drs. Yao, Razavi named National Academy of Inventors fellowsDec 3, 2019
Dr. Qizhi (Cathy) Yao and Dr. Mehdi Razavi of Baylor College of Medicine are two of the 168 academic inventors named fellows of the National Academy of Inventors.
Pack hand sanitizer, patience for healthy holiday travelNov 21, 2019
The most wonderful time of the year also is one of the most hectic times of the year. If you plan to travel this season, it is important to take precautions for your health. Experts from Baylor College of Medicine offer tips to ease your holiday travel.
Drug for high triglycerides has sustained effect at low dosagesNov 20, 2019
A drug therapy targeting the production of a protein produced by the liver has led to sustained and significant reductions in triglyceride levels using low dosages.
Study: high e-cigarette use among lesbian, gay, bisexual adultsNov 14, 2019
Researchers will give a moderated poster presentation that displays the prevalence of smoking, e-cigarette use and high-risk behaviors among adults who identify as lesbian, gay and bisexual.
Research improves understanding of atrial fibrillationOct 21, 2019
A group of researchers used a mouse model system to investigate how noncoding DNA regions that increase atrial fibrillation risk in humans work to predispose to the condition.
New insights into heart's healing capacitySep 26, 2019
A group of researchers reveals new insights into the recently discovered healing capacity of the heart involving the Hippo cellular pathway.
Grant funds study on cardiovascular disease, agingSep 5, 2019
The National Institutes of Health’s Heart, Lung, and Blood Institute has awarded Dr. Christie Ballantyne a $6 million grant to begin research to better understand how mutations contribute to atherosclerotic cardiovascular diseases.
Combining LDL cholesterol lowering drugs found effectiveMay 28, 2019
Two drugs used to lower LDL cholesterol have been proven to be even more effective when combined in a fixed dosage.
Protein found to improve prediction of cardiovascular diseaseApr 29, 2019
Researchers at Baylor College of Medicine have found that troponin I, a protein that is most commonly used to diagnose heart attack, can be detected with a new high-sensitivity assay in adults without prior cardiovascular disease or heart failure.
What you need to know about heart valve surgery and recoveryApr 3, 2019
Dr. Kenneth Liao discusses what you need to know about heart valve surgery and recovery.
Study of LDL lowering drug found no increase of adverse eventsMar 13, 2019
A study looking at safety of a new drug has found it does not increase overall adverse events or serious adverse events when compared to placebo.
Reducing risk of cardiovascular diseaseFeb 27, 2019
Dr. Christie Ballantyne,  say even if you have lowered your cholesterol and have been prescribed statins, new data shows you may still be at risk.
Findings suggest possible adult heart tissue regenerationFeb 14, 2019
An international team reports they have been able to open the possibility for treating heart disease by reprograming adult cardiomyocytes to a more fetal cell state.
Benefits of heart health supplements come with cautionsFeb 1, 2019
We’ve all heard the advice to take a fish oil with omega-3 fatty acids to improve heart health, but are you actually getting the benefits they claim to provide? Dr. Christie Ballantyne says probably not.
Statins combined with new treatment reduces cardio eventsNov 10, 2018
Researchers have shown that a particular treatment significantly reduced cardiovascular events, including cardiovascular death, in patients who continue to have high triglyceride levels on statin therapy.
Researchers find missplicing Scn5a alters cardiac functionSep 28, 2018
A new study shows that reproducing in mice the missplicing of gene Scn5a observed in patients with myotonic dystrophy type 1(DM1) recapitulates defects in cardiac function present in the patients.
New test gives better risk prediction for heart attack, strokeJul 5, 2018
Baylor College of Medicine researchers have found that testing a specific type of triglyceride may be a better indicator for predicting risk of cardiovascular disease and stroke compared to traditional risk factors.